Work

Phase II Study Of Combination Of Hyper-CVAD With Ponatinib In Front Line Therapy Of Patients (pts) With Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.2663.2663

Authors: Elias Jabbour, Hagop Kantarjian, Deborah A. Thomas, Farhad Ravandi, Jorge E. Cortes, Stefan H. Faderl, Naveen Pemmaraju, Tapan M. Kadia, Rebecca Garris, Prescott Hillary, Guillermo Garcia-Manero, Gautam Borthakur, William G. Wierda, Susan O'Brien

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4237178682

FWCI:

Cites:

Cited by: 3

Related to: 10